Braidwell LP

Braidwell LP reported 88 holdings worth US$2.41B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Braidwell LP reported 88 holdings worth US$2.41B as of Sep 30, 2026. Largest: Kodiak Sciences Inc, Caris Life Sciences, Inc. and Edgewise Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
88
Value as reported
US$2.41B

The filing in full

CompanySharesValue as reported% of portfolio
Kodiak Sciences Inc1.09MUS$103M4.3%
Caris Life Sciences, Inc.2.75MUS$84.1M3.5%
Edgewise Therapeutics, Inc.2.07MUS$84M3.5%
Alphatec Holdings, Inc.7.23MUS$74.6M3.1%
iRhythm Holdings, Inc.641KUS$72.8M3.0%
Hinge Health, Inc.655KUS$63.7M2.6%
Spyre Therapeutics, Inc.714KUS$63.6M2.6%
Xenon Pharmaceuticals Inc.1.71MUS$63.5M2.6%
NeoGenomics, Inc.3.35MUS$61.5M2.6%
Glaukos Corporation344KUS$56.5M2.3%
Vera Therapeutics, Inc.1.73MUS$55.8M2.3%
TransMedics Group, Inc.654KUS$54.6M2.3%
Intuitive Surgical, Inc.126KUS$51.2M2.1%
Aveanna Healthcare Holdings Inc.3.87MUS$48M2.0%
Neurocrine Biosciences, Inc.337KUS$47.7M2.0%
Dianthus Therapeutics, Inc.518KUS$45.6M1.9%
BrightSpring Health Services, Inc.802KUS$45.5M1.9%
Generate Biomedicines, Inc.2.96MUS$44.5M1.8%
Maravai LifeSciences Holdings, Inc.5.5MUS$42.2M1.7%
Krystal Biotech, Inc.114KUS$37.9M1.6%
Acadia Healthcare Company, Inc.1.35MUS$37.2M1.5%
Alamar Biosciences, Inc.1.08MUS$36.9M1.5%
Kymera Therapeutics, Inc.301KUS$33.6M1.4%
Nuvectis Pharma, Inc.1.57MUS$33.2M1.4%
Climb Bio, Inc.2.86MUS$32.8M1.4%
Inspire Medical Systems, Inc.464KUS$32.2M1.3%
Danaher Corporation142KUS$31.4M1.3%
Maze Therapeutics, Inc.1.15MUS$31.2M1.3%
Humana Inc.81,399US$31.1M1.3%
Monte Rosa Therapeutics, Inc.2.53MUS$30.1M1.3%
Thermo Fisher Scientific Inc41,675US$28.1M1.2%
Immunocore Holdings plc906KUS$27.4M1.1%
Nektar Therapeutics444KUS$26.9M1.1%
Oruka Therapeutics, Inc.320KUS$26.6M1.1%
Boston Scientific Corporation588KUS$25.6M1.1%
Natera, Inc.59,900US$24.8M1.0%
Evolus, Inc. Common Stock3.08MUS$24.7M1.0%
Avalo Therapeutics, Inc.1.61MUS$24.7M1.0%
OrthoPediatrics Corp.1.1MUS$24.5M1.0%
Rhythm Pharmaceuticals, Inc.256KUS$24.4M1.0%
Bright Minds Biosciences Inc.484KUS$24.1M1.0%
MBX Biosciences, Inc.399KUS$23.4M0.97%
Corvus Pharmaceuticals, Inc.1.93MUS$22.2M0.92%
Repligen Corporation112KUS$21.4M0.89%
Avalyn Pharma Inc.744KUS$21.2M0.88%
Guardant Health, Inc.118KUS$21M0.87%
Nurix Therapeutics, Inc.871KUS$20.7M0.86%
Castle Biosciences, Inc.503KUS$17.9M0.74%
Ovid Therapeutics Inc.6.58MUS$16.4M0.68%
Stryker Corporation49,560US$13.6M0.57%
ORIC Pharmaceuticals, Inc.991KUS$13.3M0.55%
Septerna, Inc.328KUS$12.8M0.53%
Cogent Biosciences, Inc.401KUS$12.8M0.53%
Adlai Nortye Group Ltd.795KUS$12.7M0.53%
LifeStance Health Group, Inc.975KUS$11.7M0.49%
Zura Bio Limited2.65MUS$11M0.46%
Surrozen, Inc.335KUS$10.8M0.45%
Electra Therapeutics, Inc.906KUS$10.2M0.42%
Seaport Therapeutics, Inc.481KUS$9.71M0.40%
Helix Acquisition Corp. III900KUS$9.47M0.39%
Quest Diagnostics Incorporated40,400US$9.42M0.39%
Aclaris Therapeutics, Inc.1.75MUS$9.23M0.38%
Tectonic Therapeutic, Inc.371KUS$8.64M0.36%
Ionis Pharmaceuticals, Inc.176KUS$7.88M0.33%
Elevance Health, Inc.19,440US$7.56M0.31%
Amanat Acquisition Corp700KUS$7.46M0.31%
BioAge Labs, Inc.1.03MUS$7.32M0.30%
X4 Pharmaceuticals, Inc.2.34MUS$6.8M0.28%
Vor Biopharma Inc.319KUS$6.09M0.25%
Immunic, Inc.645KUS$6M0.25%
ADARx Pharmaceuticals, Inc.300KUS$5.98M0.25%
Research Alliance Corporation III400KUS$4.28M0.18%
JATT III Acquisition Corp350KUS$3.91M0.16%
Attovia Therapeutics, Inc.225KUS$3.86M0.16%
Research Alliance Corporation IV300KUS$3.55M0.15%
CG Oncology, Inc.41,100US$2.91M0.12%
JATT II Acquisition Corp250KUS$2.78M0.12%
Pulmonx Corporation753KUS$1.44M0.06%
Tenax Therapeutics, Inc.584KUS$1.1M0.05%
Hemab Therapeutics Holdings, Inc.0US$00.00%
Kardigan, Inc.0US$00.00%
MannKind Corporation0US$00.00%
VYNE Therapeutics Inc.0US$00.00%
Waters Corporation0US$00.00%
ACADIA Pharmaceuticals Inc.0US$00.00%
argenx SE0US$00.00%
CareDx, Inc.0US$00.00%
Celldex Therapeutics, Inc.0US$00.00%
Cyclerion Therapeutics, Inc.0US$00.00%
Damora Therapeutics, Inc.0US$00.00%
Dyne Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related